Marine Polyketides and Their Biosynthesis
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 229
Special Issue Editor
Special Issue Information
Polyketides are one of the major classes of natural products which has structurally diverse subclasses such as aromatic polyketides, macrolactones, polyethers, polyenes, and decalin-containing scaffolds. Marine-derived polyketides have shown a wide range of pharmacological effects; for example, Eribulin (Halaven®) is a macrocyclic polyketide and has been used as an anticancer medication in the Europe and the U.S. since 2010. In the living organisms, polyketides are synthesized via polyketide synthases (PKSs) which are encoded in specific biosynthetic genes. Deciphering their biosynthesis is not only of high academic value, but also facilitates manipulation of the biosynthetic pathways to increase the production level of bioactive molecules and/or to modify their chemical structures for higher potency. Therefore, marine-derived polyketides have huge potentials across chemical, biological, and pharmacological disciplines.
This Special Issue will cover the characterization of structures and biosynthetic pathways of marine-derived novel polyketides, as well as their biological application. Both original research and review papers are welcome.
Prof. Dr. Chung Sub Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine natural products;
- polyketides;
- structure elucidation;
- biosynthesis;
- marine microbes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
